Published in BMJ on October 30, 1993
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut (2004) 1.93
Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci (2006) 1.33
Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob (2005) 1.11
The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma. Epidemiol Infect (1996) 1.10
Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis (2012) 1.09
Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony. Curr Hepat Rep (2010) 0.95
Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol (2014) 0.84
Hepatitis C comorbidities affecting the course and response to therapy. World J Gastroenterol (2009) 0.82
Clinical features and outcome of chronic viral hepatitis with acute exacerbation in patients with concurrent infections of hepatitis B and C virus. Dig Dis Sci (2007) 0.80
The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol (2015) 0.79
Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo. PLoS One (2012) 0.78
MiR-122 in hepatitis B virus and hepatitis C virus dual infection. World J Hepatol (2015) 0.78
Occult HBV infection: a faceless enemy in liver cancer development. Viruses (2014) 0.75
Concurrent infection with hepatitis B and C viruses. BMJ (1994) 0.75
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02
Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1992) 2.30
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med (1981) 2.29
Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol (1992) 2.25
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med (1984) 2.01
Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA (1990) 1.37
Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis (1979) 1.29
Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions. Lancet (1991) 1.07
Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol (1992) 1.04
Non-A, non-B hepatitis in persistent carriers of hepatitis B virus. J Med Virol (1983) 1.01
Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays. J Med Virol (1991) 0.95
Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J Med Virol (1983) 0.93
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med (1980) 9.34
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Histological Localization of Newly-formed Desoxyribonucleic Acid. Science (1948) 6.56
Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med (1996) 6.49
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med (1975) 5.49
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med (2001) 4.26
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med (1999) 4.12
Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron (1994) 4.00
Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem (1985) 3.95
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Occupational risk for hepatitis C virus infection among New York City dentists. Lancet (1992) 3.31
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol (1977) 3.07
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med (1992) 3.01
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology (1982) 2.74
Dilution assay statistics. J Clin Microbiol (1994) 2.61
Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood (1987) 2.43
Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods. J Immunol (1971) 2.35
Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature (1994) 2.35
Detection of hepatitis A viral antigen by radioimmunoassay. J Immunol (1975) 2.33
Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol (2001) 2.32
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS) Hepatology (2000) 2.30
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med (1981) 2.29
Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology (1983) 2.22
Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis (1978) 2.21
HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS. Ann Intern Med (1995) 2.18
Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet (1995) 2.17
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis (1994) 2.15
Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol (1995) 2.15
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol (1979) 2.06
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Infectious liver diseases in three groups of Copenhagen workers: correlation of hepatitis A infection to sewage exposure. Arch Environ Health (1981) 2.03
Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA (1990) 2.02
Hepatitis B virus contains pre-S gene-encoded domains. Nature (1985) 2.02
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med (1984) 2.01
The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis (1990) 2.00
Chlorhexidine droplet splash from a skin preparation gallipot: effect of height of pouring. Anaesthesia (2013) 2.00
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med (1977) 1.95
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med (1984) 1.93
Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA (1997) 1.91
Factors influencing neonatal infection by hepatitis B virus. Gastroenterology (1973) 1.91
Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. JAMA (1986) 1.90
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J Clin Microbiol (1993) 1.85
Nonparenteral transmission of viral hepatitis type B (Australia antigen-associated serum hepatitis). N Engl J Med (1971) 1.84
Distribution of antibody to hepatitis a antigen in urban adult populations. N Engl J Med (1976) 1.81
Viral hepatitis in a group of Boston hospitals. 3. Importance of exposure to shellfish in a nonepidemic period. N Engl J Med (1967) 1.75
Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis (1982) 1.74
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Viral hepatitis in Israel: the effect of canvassing physicians on notifications and the apparent epidemiological pattern. Bull World Health Organ (1972) 1.72
Stored placental blood for unrelated bone marrow reconstitution. Blood (1993) 1.72
Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol (1975) 1.72
Biophysical and biochemical heterogeneity of purified hepatitis B antigen. J Virol (1972) 1.70
Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. Am J Epidemiol (1972) 1.70
Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA (1985) 1.66
Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med (1977) 1.63
Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo. J Virol (1997) 1.63
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol (1997) 1.62
Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol (1992) 1.61
The importance of housing characteristics in determining Der p 1 levels in carpets in New Zealand homes. Clin Exp Allergy (2001) 1.61
Post-transfusion hepatitis: current perspectives. Ann Intern Med (1980) 1.60
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion (2005) 1.60
Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet (1975) 1.59
Pharmacomechanical coupling in smooth muscle may involve phosphatidylinositol metabolism. Proc Natl Acad Sci U S A (1984) 1.58
Hemifacial myohyperplasia: description of a new syndrome. Am J Med Genet (2001) 1.58
Change points in the series of T4 counts prior to AIDS. Biometrics (1995) 1.58
A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness. J Infect Dis (1998) 1.57
An epidemic of clam-associated hepatitis. JAMA (1969) 1.55
Health-related functional status in pregnancy: relationship to depression and social support in a multi-ethnic population. Obstet Gynecol (2001) 1.54
Bleeding from a Meckel's diverticulum after the use of ibuprofen. Am J Gastroenterol (1992) 1.54
Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora. Sex Transm Dis (1984) 1.53